Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nicotine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 646 Specimen Handling 633 Magnetic Resonance Spectroscopy 522 Carboplatin 433 Cyclophosphamide 398 Cisplatin 363 Biopsy 360 Nivolumab 318 Paclitaxel 308 Gemcitabine 293 Radiotherapy 271 Bevacizumab 244 fludarabine 220 Dexamethasone 215 venetoclax 205 Docetaxel 190 durvalumab 189 Oxaliplatin 187 Pemetrexed 177 atezolizumab 176 Fluorouracil 175 Rituximab 173 Doxorubicin 163 Capecitabine 163 Radiation 155 Ipilimumab 149 Radiosurgery 148 Prednisone 139 Standard of Care 138 Leucovorin 137

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05535192 2026-04-08

THRIVE-65

Dana-Farber Cancer Institute

Phase NA Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡